tiprankstipranks
CNBX Pharmaceuticals (CNBX)
OTHER OTC:CNBX

CNBX Pharmaceuticals (CNBX) Financial Statements

118 Followers

CNBX Pharmaceuticals Financial Overview

CNBX Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.059; its P/E ratio is -0.17; CNBX Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Feb 24Nov 23Aug 23May 23Feb 23
Income Statement-
Total Revenue$ 40.64K$ 89.44K$ 100.00K$ 310.17K-
Gross Profit$ 34.42K$ 89.44K$ 100.00K$ 310.17K-
EBIT$ -201.75K$ -167.07K$ -188.82K$ -154.69K$ 271.00K
EBITDA$ -168.89K$ -127.61K$ -150.33K$ -114.70K$ 311.39K
Net Income Common Stockholders$ -325.46K$ -178.52K$ -573.55K$ -154.69K$ -2.12M
Balance Sheet-
Cash Cash Equivalents And Short Term Investments$ 37.14K$ 81.65K$ 129.70K$ 44.15K$ 47.75K
Total Assets$ 163.92K$ 387.40K$ 499.04K$ 662.02K$ 462.05K
Total Debt$ 1.29M$ 1.31M$ 1.34M$ 1.33M$ 1.54M
Net Debt$ 1.26M$ 1.23M$ 1.21M$ 1.29M$ 1.49M
Total Liabilities$ 2.52M$ 2.48M$ 2.52M$ 2.57M$ 2.25M
Stockholders Equity$ -2.36M$ -2.09M$ -2.02M$ -1.91M$ -2.01M
Cash Flow-
Free Cash Flow$ -104.40K$ -73.04K$ 20.52K$ -18.59K$ -18.53K
Operating Cash Flow$ -124.40K$ -71.85K$ 20.52K$ -18.59K$ -18.53K
Investing Cash Flow$ 20.00K$ -1.20K--$ 24.70K
Financing Cash Flow-$ 24.99K$ 65.03K$ 14.99K$ 19.98K
Currency in USD

CNBX Pharmaceuticals Earnings and Revenue History

CNBX Pharmaceuticals Debt to Assets

CNBX Pharmaceuticals Cash Flow

CNBX Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis